$2.45
0.052.08%
At close: -
$2.40
-0.05-2.04%
After Hours: 4:00 PM EDT
Comments
Loading...
Artiva Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ARTV | Benzinga
Artiva Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 22
EPS Estimate
$-0.660
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$251.00K
Analyze the earnings history of Artiva Biotherapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARTV | Artiva Biotherapeutics | — | -$0.66 | — | — | — | — | — | — | 05/22/2025 | Get Alert |
| ARTV | Artiva Biotherapeutics | — | -$0.62 | -$0.66 | -6.45% | — | — | $0.00 | — | 03/24/2025 | Get Alert |
| ARTV | Artiva Biotherapeutics | $1.62 | -$0.91 | -$0.92 | -1.10% | $26.66M | $70.00K | $0.00 | -100.00% | 11/12/2024 | Get Alert |
| ARTV | Artiva Biotherapeutics | -$14.09 | -$4.40 | -$22.00 | -400.00% | $3.50M | $70.00K | $0.00 | -100.00% | 08/29/2024 | Get Alert |
Artiva Biotherapeutics (ARTV) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-24 | $-0.66 | $-0.62 | -6.45 % |
| Q3 | 2024-11-12 | $-0.92 | $-0.91 | -1.10 % |
| Q2 | 2024-08-29 | $-22.00 | $-4.40 | -400.0 % |
Artiva Biotherapeutics (ARTV) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $0 | $70.00K | -100.0 % |
| Q2 | 2024-08-29 | $0 | $70.00K | -100.0 % |
FAQ
When is Artiva Biotherapeutics (NASDAQ:ARTV) reporting earnings?
Artiva Biotherapeutics (ARTV) is scheduled to report earnings on May 22, 2025. The last reported earnings were for reported on March 24, 2025 for Q4.
What were the latest earnings per share (EPS) for Artiva Biotherapeutics (NASDAQ:ARTV)?
The Actual EPS was $-0.66, which missed the estimate of $-0.62.
What were Artiva Biotherapeutics’s (NASDAQ:ARTV) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
